Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-07-000017
Filing Date
2007-01-26
Accepted
2007-01-26 12:28:42
Documents
1
Period of Report
2006-01-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 10095
  Complete submission text file 0001235802-07-000017.txt   12163
Mailing Address C/O HARRIS ASSOCIATES LP TWO NORTH LASALLE STREET CHICAGO IL 60602
Business Address C/O HARRIS ASSOCIATES LP TWO NORTH LASALLE STREET, STE 500 CHICAGO IL 60602-3790
MORGENSTERN VICTOR A (Reporting) CIK: 0000929635 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31812 | Film No.: 07555382

Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)